SW
SRNE

SlateStone Wealth’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

SlateStone Wealth’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-21,433
Closed – – 303
2024
Q3 		$0 Hold
21,433
– – ﹤0.01% 306
2024
Q2 		$0 Hold
21,433
– – ﹤0.01% 301
2024
Q1 		$0 Hold
21,433
– – ﹤0.01% 291
2023
Q4 		$3K Sell
21,433
-9,433
-31% -$1.32K ﹤0.01% 239
2023
Q3 		$3K Hold
30,866
– – ﹤0.01% 226
2023
Q2 		$11K Buy
30,866
+9,433
+44% +$3.36K ﹤0.01% 210
2023
Q1 		$8K Hold
21,433
– – ﹤0.01% 205
2022
Q4 		$19K Sell
21,433
-18,867
-47% -$25K ﹤0.01% 194
2022
Q3 		$63K Hold
40,300
– – 0.02% 181
2022
Q2 		$81K Hold
40,300
– – 0.02% 180
2022
Q1 		$94K Hold
40,300
– – 0.02% 178
2021
Q4 		$187K Sell
40,300
-9,433
-19% -$58.6K 0.04% 173
2021
Q3 		$379K Hold
49,733
– – 0.09% 127
2021
Q2 		$482K Hold
49,733
– – 0.11% 119
2021
Q1 		$411K Hold
49,733
– – 0.1% 121
2020
Q4 		$339K Buy
49,733
+37,733
+314% +$303K 0.08% 135
2020
Q3 		$134K Hold
12,000
– – 0.03% 170
2020
Q2 		$75K Hold
12,000
– – 0.02% 169
2020
Q1 		$22K Hold
12,000
– – 0.01% 171
2019
Q4 		$41K Buy
+12,000
New +$28.6K 0.01% 211

Other funds holding SRNE

KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
LCM
Lattice Capital Management Kirkland, Washington $49.5M AUM 28.58% 1-Year Est. Return
HAG
HighPoint Advisor Group Downers Grove, Illinois $2.84B AUM 31.94% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

SlateStone Wealth's SRNE Position: Q4 2024 in Review

SlateStone Wealth sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2024, closing a stake of 21,433 shares.

SlateStone Wealth first reported a position in SRNE in Q4 2019 and held it in 20 quarters. The position peaked at $482K in Q2 2021. 5 funds tracked by Wall St. Rank hold SRNE as of Q4 2024.

  • SlateStone Wealth reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2024 after selling out during the quarter.
  • SlateStone Wealth sold 21,433 Sorrento Therapeutics, Inc. shares in Q4 2024.
  • SlateStone Wealth first reported a position in Sorrento Therapeutics, Inc. in Q4 2019 and held it in 20 quarters.
  • SlateStone Wealth's Sorrento Therapeutics, Inc. position peaked at $482K in Q2 2021.
  • 5 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2024.

Based on SlateStone Wealth's 13F filing for Q4 2024, filed 10 Feb 2025.